Keyphrases
Thrombosis
100%
Myeloproliferative Neoplasms
100%
Bleeding Complications
100%
Thrombotic Complications
100%
Thrombotic
50%
Hemorrhagic Complications
50%
Risk Factors
25%
Novel Therapies
25%
Polycythemia Vera
25%
Interferon-α (IFN-α)
25%
Von Willebrand Disease
25%
New mutation
25%
Advanced Age
25%
Thrombosis Risk
25%
Phlebotomy
25%
Anticoagulant Therapy
25%
JAK Inhibitors
25%
Hematocrit
25%
JAK2V617F mutation
25%
Emerging Risk
25%
BCR-ABL Negative
25%
Philadelphia-negative Myeloproliferative Neoplasms
25%
Leukocytosis
25%
Cytoreductive Surgery
25%
Aspirin Therapy
25%
Allele Burden
25%
Abdominal Veins
25%
Platelet Defects
25%
Extreme Thrombocytosis
25%
Medicine and Dentistry
Bleeding
100%
Myeloproliferative Neoplasm
100%
Thrombosis
80%
Leukocytosis
20%
Hematocrit
20%
Anticoagulation
20%
Acetylsalicylic Acid
20%
Bleeding Diathesis
20%
Philadelphia 1 Chromosome
20%
Polycythemia vera
20%
Janus Kinase Inhibitor
20%
Thrombocytosis
20%
Thrombocyte Anomaly
20%
Thrombotic Risk Factor
20%
Phlebotomy
20%
Janus Kinase
20%
Interferon
20%